Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Series

2022

Beaumont Health

Prostate neoplasms

Articles 1 - 3 of 3

Full-Text Articles in Medicine and Health Sciences

Roundtable Discussion: 68-Year-Old Man With Mhspc, Jason M. Hafron Sep 2022

Roundtable Discussion: 68-Year-Old Man With Mhspc, Jason M. Hafron

Articles

No abstract provided.


Case Discussion: 66-Year-Old Man With Low-Volume Prostate Cancer, Jason M. Hafron Sep 2022

Case Discussion: 66-Year-Old Man With Low-Volume Prostate Cancer, Jason M. Hafron

Articles

An interview with Michigan Institute of Urology's Doctor Jason M. Hafron is presented. He presents a case of a 66-year-old male with low-volume prostate cancer to discuss his possible prognosis and the risk group he should be categorized. He explains his preferred approach to treat the patient like ordering a bone scan, computed tomography (CT) of the chest, abdomen and pelvis, and germline testing. He recommends some treatments for metastatic castration-sensitive prostate cancer (CSPC).


Isopsa: Clinical Performance Of A Single Parameter, Structure Based Test For High Grade Prostate Cancer Unaffected By 5-Ari And A-Blocker Medications, Eric Klein, Alan Partin, Yair Lotan, Jack Baniel, Martin Dineen, Jason Hafron, Kannan Manickam, Marc Pliskin, Matthew Wagnet, Ao Zhang Aug 2022

Isopsa: Clinical Performance Of A Single Parameter, Structure Based Test For High Grade Prostate Cancer Unaffected By 5-Ari And A-Blocker Medications, Eric Klein, Alan Partin, Yair Lotan, Jack Baniel, Martin Dineen, Jason Hafron, Kannan Manickam, Marc Pliskin, Matthew Wagnet, Ao Zhang

Website/Multimedia Contributions

No abstract provided.